Cherrystone Angel Group Appoints Patrice Milos Executive Director

Share on Social Media

Patrice MilosProvidence, RI – The Cherrystone Angel Group, announces the appointment of Patrice Milos, PhD as Executive Director effective May 1st, 2020. 

 “A seasoned executive with both highly innovative entrepreneurship and corporate experiences, Patrice brings a wealth of knowledge regarding innovation occurring in the Northeast region. Her visionary work in life sciences, diagnostics, software and digital healthcare nicely complement many of the business opportunities Cherrystone sees as important future opportunities for our angel investors, “ said Robert Manning, Chairman of Cherrystone. “Special thanks to our former Executive Director Bert Lederer, who has done an amazing job over the last three years.   His leadership has positioned the group well for continued success.”

“I look forward to working with our Cherrystone Angels at a time when the innovative companies in our growing portfolio and our region are ever more essential to moving our economy forward,” said Dr. Milos. “This is a key time for our entrepreneurial community and we look forward to working with early stage companies as they deliver on the promise of significant growth and economic impact for our region.  I am pleased to be working with such a great group of seasoned early stage investors.”

Dr. Milos will continue her efforts as president/CEO of Medley Genomics, a life sciences company dedicated to addressing the challenges of genomic heterogeneity in the diagnosis and treatment of complex diseases. She serves as the Board Chair for RI BIO and serves on the RI Hub Venture Mentoring Steering Committee, is an active NIH SBIR grant reviewer. Prior to her current position, Dr. Milos was president/CEO at Claritas Genomics in Cambridge, MA and held senior executive roles at Pfizer Inc.  She conducted post-doctoral fellowships at Brown University and Harvard University and earned her PhD at Rensselaer Polytechnic Institute in Troy, NY.

About Cherrystone Angel Group 

Cherrystone Angel Group offers early stage investment funds to companies in need of capital growth, primarily in New England. Our group is made up of seasoned veterans in various industries who not only bring investable funds but expertise to our portfolio teams. The group works closely with founding teams in the early stages of companies to help them grow and achieve success.

Contact:  For more information send inquires to [email protected]

Latest News

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

PROVIDENCE, RI–April 26, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced their slate of NEXT WAVE events with Venture Café Providence every Thursday in May that celebrates the life sciences.  “The pandemic put advances in life sciences and...

RI Bio Board Appoints Two New Directors

RI Bio Board Appoints Two New Directors

PROVIDENCE, RI–March 16, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced the appointment of two new members to its board of directors at its March 16 meeting: Neil Sarkar of the Rhode Island Quality Institute (RIQI) and Jaimy Mauricio of...

Biotech Industry News